MTOR and renal cell carcinoma: Pathways such as the intestinal immune network for mTOR signaling, fatty acid metabolism, the citrate cycle (TCA cycle), renal cell carcinoma, and peroxisome pathways were enriched in high-risk patients, suggesting the alterations in this pathway may contribute to the aggressive behavior of tumors in high-risk patients.